Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 13 studies | 24% ± 6% | |
lung | 7 studies | 23% ± 6% | |
brain | 5 studies | 26% ± 7% | |
lymph node | 4 studies | 18% ± 1% | |
bone marrow | 3 studies | 16% ± 1% | |
eye | 3 studies | 18% ± 3% | |
uterus | 3 studies | 28% ± 15% | |
intestine | 3 studies | 23% ± 6% | |
liver | 3 studies | 23% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 4905.71 | 258 / 258 | 100% | 57.69 | 230 / 230 |
bladder | 100% | 4062.81 | 21 / 21 | 100% | 56.48 | 504 / 504 |
esophagus | 100% | 4492.44 | 1445 / 1445 | 100% | 43.39 | 183 / 183 |
kidney | 100% | 3317.71 | 89 / 89 | 100% | 55.99 | 901 / 901 |
liver | 100% | 2647.03 | 226 / 226 | 100% | 35.50 | 406 / 406 |
ovary | 100% | 4102.14 | 180 / 180 | 100% | 36.80 | 430 / 430 |
prostate | 100% | 3837.99 | 245 / 245 | 100% | 59.28 | 502 / 502 |
stomach | 100% | 3141.76 | 359 / 359 | 100% | 46.00 | 286 / 286 |
uterus | 100% | 4187.56 | 170 / 170 | 100% | 50.76 | 459 / 459 |
breast | 100% | 4126.54 | 459 / 459 | 100% | 59.87 | 1117 / 1118 |
brain | 100% | 4501.18 | 2639 / 2642 | 100% | 62.46 | 705 / 705 |
thymus | 100% | 3775.10 | 652 / 653 | 100% | 54.72 | 605 / 605 |
intestine | 100% | 4372.08 | 966 / 966 | 100% | 53.13 | 526 / 527 |
lung | 100% | 3715.20 | 577 / 578 | 100% | 52.07 | 1154 / 1155 |
pancreas | 99% | 1789.63 | 324 / 328 | 100% | 48.19 | 178 / 178 |
skin | 100% | 4647.30 | 1809 / 1809 | 97% | 44.43 | 460 / 472 |
adipose | 100% | 4199.30 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3968.30 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 67.56 | 29 / 29 |
muscle | 100% | 5391.70 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4013.76 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 41.25 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 25.63 | 1 / 1 |
heart | 99% | 4265.79 | 850 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 3314.31 | 891 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 30.01 | 75 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0009408 | Biological process | response to heat |
GO_0042026 | Biological process | protein refolding |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0051082 | Molecular function | unfolded protein binding |
GO_0030544 | Molecular function | Hsp70 protein binding |
GO_0051087 | Molecular function | protein-folding chaperone binding |
GO_0005515 | Molecular function | protein binding |
GO_0001671 | Molecular function | ATPase activator activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | DNAJA2 |
Protein name | DnaJ homolog subfamily A member 2 (Cell cycle progression restoration gene 3 protein) (Dnj3) (Dj3) (HIRA-interacting protein 4) (Renal carcinoma antigen NY-REN-14) DnaJ heat shock protein family (Hsp40) member A2 DnaJ homolog subfamily B member 9 (Endoplasmic reticulum DNA J domain-containing protein 4) |
Synonyms | HIRIP4 CPR3 |
Description | FUNCTION: Co-chaperone of Hsc70. Stimulates ATP hydrolysis and the folding of unfolded proteins mediated by HSPA1A/B (in vitro) . . |
Accessions | ENST00000317089.10 A0A087WT48 ENST00000617000.1 O60884 I3L320 ENST00000563158.1 |